• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ABCC6 转运蛋白在肝细胞中的结构与功能特征:在 PXE、癌症治疗和耐药性中的作用。

Structural and Functional Characterization of the ABCC6 Transporter in Hepatic Cells: Role on PXE, Cancer Therapy and Drug Resistance.

机构信息

Department of Sciences, University of Basilicata, 85100 Potenza, Italy.

出版信息

Int J Mol Sci. 2021 Mar 11;22(6):2858. doi: 10.3390/ijms22062858.

DOI:10.3390/ijms22062858
PMID:33799762
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8000515/
Abstract

Pseudoxanthoma elasticum (PXE) is a complex autosomal recessive disease caused by mutations of ABCC6 transporter and characterized by ectopic mineralization of soft connective tissues. Compared to the other ABC transporters, very few studies are available to explain the structural components and working of a full ABCC6 transporter, which may provide some idea about its physiological role in humans. Some studies suggest that mutations of in the liver lead to a decrease in some circulating factor and indicate that PXE is a metabolic disease. It has been reported that ABCC6 mediates the efflux of ATP, which is hydrolyzed in PPi and AMP; in the extracellular milieu, PPi gives potent anti-mineralization effect, whereas AMP is hydrolyzed to Pi and adenosine which affects some cellular properties by modulating the purinergic pathway. Structural and functional studies have demonstrated that silencing or inhibition of ABCC6 with probenecid changed the expression of several genes and proteins such as and TNAP, as well as Lamin, and CDK1, which are involved in cell motility and cell cycle. Furthermore, a change in cytoskeleton rearrangement and decreased motility of HepG2 cells makes ABCC6 a potential target for anti-cancer therapy. Collectively, these findings suggested that ABCC6 transporter performs functions that modify both the external and internal compartments of the cells.

摘要

弹性假黄瘤(PXE)是一种由 ABCC6 转运蛋白基因突变引起的复杂常染色体隐性疾病,其特征是软结缔组织的异位矿化。与其他 ABC 转运蛋白相比,很少有研究能够解释完整 ABCC6 转运蛋白的结构组成和工作原理,这可能为其在人类中的生理作用提供一些思路。一些研究表明,肝脏中的突变导致一些循环因子的减少,并表明 PXE 是一种代谢疾病。据报道,ABCC6 介导 ATP 的外排,ATP 在 PPi 和 AMP 中水解;在细胞外环境中,PPi 具有很强的抗矿化作用,而 AMP 则水解为 Pi 和腺苷,通过调节嘌呤能途径影响一些细胞特性。结构和功能研究表明,用丙磺舒沉默或抑制 ABCC6 会改变几种基因和蛋白质的表达,如和 TNAP,以及 Lamin 和 CDK1,它们参与细胞运动和细胞周期。此外,细胞骨架重排的变化和 HepG2 细胞运动能力的降低使 ABCC6 成为抗癌治疗的潜在靶点。综上所述,这些发现表明 ABCC6 转运蛋白具有修饰细胞内外区室的功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085f/8000515/a3a2ce6b2fe2/ijms-22-02858-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085f/8000515/53fcbcc62268/ijms-22-02858-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085f/8000515/10a2e72b8a75/ijms-22-02858-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085f/8000515/236e046f4b31/ijms-22-02858-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085f/8000515/9705e1ce2319/ijms-22-02858-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085f/8000515/ab701b651d32/ijms-22-02858-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085f/8000515/49c4118e64d4/ijms-22-02858-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085f/8000515/a3a2ce6b2fe2/ijms-22-02858-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085f/8000515/53fcbcc62268/ijms-22-02858-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085f/8000515/10a2e72b8a75/ijms-22-02858-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085f/8000515/236e046f4b31/ijms-22-02858-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085f/8000515/9705e1ce2319/ijms-22-02858-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085f/8000515/ab701b651d32/ijms-22-02858-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085f/8000515/49c4118e64d4/ijms-22-02858-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085f/8000515/a3a2ce6b2fe2/ijms-22-02858-g007.jpg

相似文献

1
Structural and Functional Characterization of the ABCC6 Transporter in Hepatic Cells: Role on PXE, Cancer Therapy and Drug Resistance.ABCC6 转运蛋白在肝细胞中的结构与功能特征:在 PXE、癌症治疗和耐药性中的作用。
Int J Mol Sci. 2021 Mar 11;22(6):2858. doi: 10.3390/ijms22062858.
2
ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release.ABCC6 通过诱导细胞核苷酸释放来防止弹性假黄瘤中所见的异位矿化。
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20206-11. doi: 10.1073/pnas.1319582110. Epub 2013 Nov 25.
3
knockdown in HepG2 cells induces a senescent-like cell phenotype.在肝癌细胞系HepG2中敲低会诱导出类似衰老的细胞表型。
Cell Mol Biol Lett. 2017 Apr 4;22:7. doi: 10.1186/s11658-017-0036-2. eCollection 2017.
4
The ABCC6 Transporter: A New Player in Biomineralization.ABCC6转运蛋白:生物矿化中的新角色。
Int J Mol Sci. 2017 Sep 11;18(9):1941. doi: 10.3390/ijms18091941.
5
ABCC6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation-brief report.肝脏中ABCC6介导的ATP分泌是全身循环中矿化抑制剂无机焦磷酸的主要来源——简报
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1985-9. doi: 10.1161/ATVBAHA.114.304017. Epub 2014 Jun 26.
6
Structural analysis reveals pathomechanisms associated with pseudoxanthoma elasticum-causing mutations in the ABCC6 transporter.结构分析揭示了与 ABCC6 转运蛋白相关的假性弹性假黄瘤致病突变的发病机制。
J Biol Chem. 2018 Oct 12;293(41):15855-15866. doi: 10.1074/jbc.RA118.004806. Epub 2018 Aug 28.
7
ABCC6, Pyrophosphate and Ectopic Calcification: Therapeutic Solutions.ABCC6、焦磷酸盐与异位钙化:治疗方案
Int J Mol Sci. 2021 Apr 27;22(9):4555. doi: 10.3390/ijms22094555.
8
Inhibition of Tissue-Nonspecific Alkaline Phosphatase Attenuates Ectopic Mineralization in the Abcc6 Mouse Model of PXE but Not in the Enpp1 Mutant Mouse Models of GACI.抑制组织非特异性碱性磷酸酶可减轻 Abcc6 小鼠 PXE 模型中的异位矿化,但不能减轻 Enpp1 突变小鼠 GACI 模型中的异位矿化。
J Invest Dermatol. 2019 Feb;139(2):360-368. doi: 10.1016/j.jid.2018.07.030. Epub 2018 Aug 18.
9
Pseudoxanthoma elasticum: molecular genetics and putative pathomechanisms.弹性假黄瘤:分子遗传学和可能的发病机制。
J Invest Dermatol. 2010 Mar;130(3):661-70. doi: 10.1038/jid.2009.411. Epub 2009 Dec 24.
10
Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6).人类ABCC6(多药耐药相关蛋白6,MRP6)弹性假黄瘤相关突变体中ATP依赖转运活性的丧失
J Biol Chem. 2002 May 10;277(19):16860-7. doi: 10.1074/jbc.M110918200. Epub 2002 Mar 5.

引用本文的文献

1
The 75-99 C-Terminal Peptide of URG7 Protein Promotes α-Synuclein Disaggregation.URG7 蛋白的 75-99 C 端肽促进 α-突触核蛋白解聚。
Int J Mol Sci. 2024 Jan 17;25(2):1135. doi: 10.3390/ijms25021135.
2
A Regulator Role for the ATP-Binding Cassette Subfamily C Member 6 Transporter in HepG2 Cells: Effect on the Dynamics of Cell-Cell and Cell-Matrix Interactions.ATP 结合盒亚家族 C 成员 6 转运蛋白在 HepG2 细胞中的调节作用:对细胞-细胞和细胞-基质相互作用动态的影响。
Int J Mol Sci. 2023 Nov 16;24(22):16391. doi: 10.3390/ijms242216391.
3
Progress and challenges of multidrug resistance proteins in diseases.

本文引用的文献

1
Therapeutics Development for Pseudoxanthoma Elasticum and Related Ectopic Mineralization Disorders: Update 2020.弹力纤维假黄瘤及相关异位矿化障碍的治疗进展:2020年更新
J Clin Med. 2020 Dec 31;10(1):114. doi: 10.3390/jcm10010114.
2
Human ABCB1 with an ABCB11-like degenerate nucleotide binding site maintains transport activity by avoiding nucleotide occlusion.具有 ABCB11 样退化核苷酸结合位点的人 ABCB1 通过避免核苷酸封闭来维持转运活性。
PLoS Genet. 2020 Oct 8;16(10):e1009016. doi: 10.1371/journal.pgen.1009016. eCollection 2020 Oct.
3
Inhibition of ABCC6 Transporter Modifies Cytoskeleton and Reduces Motility of HepG2 Cells via Purinergic Pathway.
多药耐药蛋白在疾病中的研究进展与挑战
Am J Cancer Res. 2022 Oct 15;12(10):4483-4501. eCollection 2022.
4
A curated binary pattern multitarget dataset of focused ATP-binding cassette transporter inhibitors.经策展的靶向 ATP 结合盒转运蛋白抑制剂二值模式多靶标数据集。
Sci Data. 2022 Jul 26;9(1):446. doi: 10.1038/s41597-022-01506-z.
5
The Expression Level of ABCC6 Transporter in Colon Cancer Cells Correlates with the Activation of Different Intracellular Signaling Pathways.结肠癌中ABCC6转运蛋白的表达水平与不同细胞内信号通路的激活相关。
Pathophysiology. 2022 May 12;29(2):173-186. doi: 10.3390/pathophysiology29020015.
6
ABC Transporters in Human Diseases: Future Directions and Therapeutic Perspectives.ABC 转运蛋白在人类疾病中的作用:未来方向和治疗前景。
Int J Mol Sci. 2022 Apr 12;23(8):4250. doi: 10.3390/ijms23084250.
7
A Novel Idiopathic Atrial Calcification: Pathologic Manifestations and Potential Mechanism.一种新型特发性心房钙化:病理表现及潜在机制
Front Cardiovasc Med. 2022 Mar 21;9:788958. doi: 10.3389/fcvm.2022.788958. eCollection 2022.
ABCC6 转运蛋白抑制剂通过嘌呤能途径改变 HepG2 细胞的细胞骨架并降低其迁移能力。
Cells. 2020 Jun 5;9(6):1410. doi: 10.3390/cells9061410.
4
Role of the Nuclear Lamina in Age-Associated Nuclear Reorganization and Inflammation.核纤层在与年龄相关的核重排和炎症中的作用。
Cells. 2020 Mar 14;9(3):718. doi: 10.3390/cells9030718.
5
The P-glycoprotein inhibitor diltiazem-like 8-(4-chlorophenyl)-5-methyl-8-[(2Z)-pent-2-en-1-yloxy]-8H-[1,2,4]oxadiazolo[3,4-c][1,4]thiazin-3-one inhibits esterase activity and H3 histone acetylation.P-糖蛋白抑制剂地尔硫䓬类似物 8-(4-氯苯基)-5-甲基-8-[(2Z)-戊-2-烯-1-基氧基]-8H-[1,2,4]恶二唑[3,4-c][1,4]噻嗪-3-酮抑制酯酶活性和 H3 组蛋白乙酰化。
Eur J Med Chem. 2019 Feb 15;164:1-7. doi: 10.1016/j.ejmech.2018.12.037. Epub 2018 Dec 17.
6
Structural characterization of the L0 cytoplasmic loop of human multidrug resistance protein 6 (MRP6).人多药耐药蛋白 6(MRP6)L0 胞质环的结构特征。
Biochim Biophys Acta Biomembr. 2019 Feb 1;1861(2):380-386. doi: 10.1016/j.bbamem.2018.11.002. Epub 2018 Nov 10.
7
Extracellular ATP Regulates CD73 and ABCC6 Expression in HepG2 Cells.细胞外ATP调节HepG2细胞中CD73和ABCC6的表达。
Front Mol Biosci. 2018 Aug 14;5:75. doi: 10.3389/fmolb.2018.00075. eCollection 2018.
8
Structural analysis reveals pathomechanisms associated with pseudoxanthoma elasticum-causing mutations in the ABCC6 transporter.结构分析揭示了与 ABCC6 转运蛋白相关的假性弹性假黄瘤致病突变的发病机制。
J Biol Chem. 2018 Oct 12;293(41):15855-15866. doi: 10.1074/jbc.RA118.004806. Epub 2018 Aug 28.
9
Targeting Nucleotide Binding Domain of Multidrug Resistance-associated Protein-1 (MRP1) for the Reversal of Multi Drug Resistance in Cancer.靶向多药耐药相关蛋白 1(MRP1)的核苷酸结合域逆转肿瘤多药耐药。
Sci Rep. 2018 Aug 10;8(1):11973. doi: 10.1038/s41598-018-30420-x.
10
Multifaceted structures and mechanisms of ABC transport systems in health and disease.ABC 转运系统在健康和疾病中的多方面结构和机制。
Curr Opin Struct Biol. 2018 Aug;51:116-128. doi: 10.1016/j.sbi.2018.03.016. Epub 2018 Apr 9.